Announcement PDF ASX Release 6 April 2023 RESULTS OF GENERAL MEETING In accordance with Listing Rule 3.13.2 and Section 251AA of the Corporations Act, we advise details of the resolutions and the proxies received in respect of each resolution as set out in the attached proxy summary. Yours faithfully Invion Limited Claire Newstead-Sinclair Company Secretary This announcement is authorised for release by the Board of Directors of Invion Limited. For more information please contact: Investor enquiries Thian Chew (Chairman) E: investor@inviongroup.com Media enquires Brendon Lau T: 0409 341 613 E: brendon@vantagepointpartners.com.au Invion Limited ABN 76 094 730 417 Level 4, 100 Albert Road, South Melbourne, VIC, 3205, Australia P: +61 9692 7222 W: www.inviongroup.com Invion Limited 2023 General Meeting Thursday, 6 April 2023 Voting Results The following information is provided in accordance with section 251AA(2) of Corporations Act 2001 (Cth) *Votes cast by a person who abstains on an item are not counted in calculating the required majority on a poll Show of Hands (S) or Poll (P) Resolution Details Resolution 1. Approval to acquire a licence and distribution rights to Next Generation Photodynamic Therapy (NGPDT) from RMW Cho Group Limited Resolution Type Ordinary If s250U applies N/A Instructions given to validly appointed proxies (as at proxy close) Proxy’s S or P For Against P 721,017,599 99.54% 0 0.% 0 Res. Results For Against Abstain* Carried/ Not Carried 767,907,337 100% 0 0% - Carried Abstain Discretion 3,305,972 0.46% Number of votes cast on the poll (where applicable)